This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback